Pierre Regibeau, Dec 20, 2013
Antitrust concerns about “pay-for-delay” patent settlements are based on two theories of harms, one that stresses the need for courts to review the validity of patents and one that emphasizes the “probabilistic” nature of patent rights. The main weakness of the first theory of harm is that it fails to explain why some forms of patent settlements would be less desirable than others. The “probabilistic” theory of harm raises fundamental questions about the legal obligations of a patent-holder, the type of uncertainty that should be reflected in the probabilistic nature of the patents and whether the theory can be applied to anything but the simplest PFD settlements. This article also discusses the likely effect of a PFD ban on innovation and reviews both the European approach to recent and ongoing PFD cases and the recent Actavis decision of the US Supreme Court.
Featured News
Amazon Loses Bid to Delay FTC Antitrust Trial as California Case Looms
Oct 11, 2026 by
CPI
Nvidia Weighs Buying Reflection AI
Oct 11, 2026 by
CPI
UK Weighs Macquarie Remedy for Energy Assets Deal
Oct 11, 2026 by
CPI
UniCredit’s Commerzbank Deal Faces EU Scrutiny
Oct 11, 2026 by
CPI
US Justice Department Probes TV Networks Over White House Coverage Halt
Oct 11, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – National Security
Sep 22, 2026 by
CPI
National Security in U.S. Antitrust Enforcement: Toward a More Disciplined Framework
Sep 22, 2026 by
Rod Rosenstein & Timothy Finley
The Department of War’s M&A Review Guidance: What Companies in the Defense Industry Need to Know
Sep 22, 2026 by
Eric Stocking & Paul Ney
National Security, Resilience and the Boundaries of Merger Control
Sep 22, 2026 by
Beatriz Marques
National Security and Competition: Building Resilient Telecommunications Networks
Sep 22, 2026 by
Roslyn Layton